Literature DB >> 8740116

Therapy of Lyme borreliosis in children.

L Krbkova1, G Stanek.   

Abstract

A retrospective open study was conducted to determine the efficacy of penicillin and ceftriaxone in children with skin manifestations of Lyme borreliosis (solitary erythema migrans, multiple erythemata, borrelial lymphocytoma) and neuroborreliosis, respectively. One hundred sixty children were treated with penicillin and 41 with ceftriaxone for an average of 12 days. Serum antibodies to borreliae were determined before therapy and 2-3 and 4-6 weeks thereafter. At admission 44%/26%,8%/42%, and 40%/35% of erythema migrans, borrelial lymphocytoma and neuroborreliosis patients, respectively, were IgM/IgG positive. Four to 6 weeks after treatment the percentage of seropositives was 20%/15%,8%/61%, and 21%/44%, respectively. A 3 months follow-up was completed with 151 children. No child showed clinical evidence of illness, nor were there abnormalities in laboratory parameters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740116     DOI: 10.1007/bf01713333

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Neurologic complications of erythema-migrans-disease in childhood--clinical aspects.

Authors:  H J Christen; F Hanefeld
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-02

2.  Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.

Authors:  M Del Rio; G H McCracken; J D Nelson; D Chrane; S Shelton
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

Review 3.  Treatment of Lyme borreliosis with emphasis on neurological disease.

Authors:  B Sköldenberg; G Stiernstedt; M Karlsson; B Wretlind; B Svenungsson
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Facial paralysis in Lyme disease.

Authors:  J R Clark; R D Carlson; C T Sasaki; A R Pachner; A C Steere
Journal:  Laryngoscope       Date:  1985-11       Impact factor: 3.325

5.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  In vitro and in vivo susceptibility of Borrelia burgdorferi.

Authors:  V P Mursic; B Wilske; G Schierz; M Holmburger; E Süss
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

7.  Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis.

Authors:  H W Pfister; V Preac-Mursic; B Wilske; E Schielke; F Sörgel; K M Einhäupl
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

8.  Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge.

Authors:  M M Millner; R R Müllegger; K D Spork; G Stanek
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

9.  Lyme borreliosis in children. A controlled clinical study based on ELISA values.

Authors:  M Millner; M G Schimek; D Spork; M Schnizer; G Stanek
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

10.  Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study.

Authors:  H W Pfister; V Preac-Mursic; B Wilske; K M Einhäupl
Journal:  Arch Neurol       Date:  1989-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.